Pluto Bioinformatics

GSE137833: Androgen Receptor Degraders Overcome Common Resistance Mechanisms Developed During Prostate Cancer Treatment

Bulk RNA sequencing

RNA-sequencing of VCaP and LNCaP, LNCaP-EnzR, or LNCaP AR-V7 overexpressing prostate cancer cell lines treated with AR degrader ARD-61. SOURCE: Steven Kregel (skregel@umich.edu) - Chinnaiyan University of Michigan